Asthma and COPD together create an enormous public health burden and an urgent need for progress in disease understanding, therapy and care. Join us at our 11th annual
Asthma & COPD conference to share in the experiences of leading lights in the field who are addressing the challenges of solving the riddle of pathogenesis, biomarkers and endpoints, personalising therapies vs. the unmet need, tackling the causes and consequences of exacerbations, development of new animal models and better tools for disease diagnosis and monitoring.
This conference will give delegates invaluable insights into the key thinking and advances in the respiratory drug market, focusing on the challenges and solutions to enhance patient outcomes, providing extensive knowledge from the key leading industry, academic and care providing experts.
Benefits of Attending
- Explore the future of asthma and COPD treatment from a range of key perspectives
- Discover advances in inhaled therapies
- Discuss personalised therapy approaches, asthma patient stratification and unmet needs
- Share in the latest thinking from the clinic to improve the lives of patients
- Explore the latest thinking on biomarkers and clinical trial endpoints
- Update on mechanisms and treatment for viral induced COPD and asthma exacerbations
Plus An Interactive Half-Day Post-Conference Workshop | 15th April 2015
The power of functional respiratory imaging to define new endpoints and drive successful respiratory drug developmentWorkshop Leaders: Dr. Vos Wim, Chief Technology Officer, FLUIDDA,
Prof. Dr. Wilfried De Backer, Director, Professor of Pulmonary Medicine, University Hospital and University of Antwerp
8.30am - 12.30pm
Speakers
- Andrew Bush, Professor of Paediatric Respirology, Imperial College London and Royal Brompton Hospital
- Antonio Gomez-Munoz, Professor of Biochemistry and Molecular Biology, University of the Basque Country
- Clare Lloyd, Professor of Respiratory Immunology, Imperial College London
- Dirk Smith, Scientific Director, Amgen
- Hector Ortega, Medical Director, Respiratory R&D, GSK
- James Pinchin, Research Fellow, Horizon DERC, The University of Nottingham
- Jan-Anders Karlsson, CEO, Verona Pharma
- Jim Wild, Professor of Magnetic Resonance Physics, University of Sheffield
- John Blakey, Senior Clinical Lecturer, Liverpool School of Tropical Medicine
- John Hurst, Consultant in Respiratory Medicine, University College London
- Joseph Arron, Associate Director, Biomarker Discovery, Genentech, Inc.
- Kirsten Kaiser, Executive Vice President Medical & Regulatory Development, SkyePharma AG
- Maria Buxton, Consultant Respiratory Physiotherapist, London North West Healthcare NHS Trust
- Neelima Khairatkar-Joshi, Sr. VP & Head, NCE Drug Discovery, Glenmark Pharmaceutials Ltd.
- Neil C Thomson, Professor of Respiratory Medicine, University of Glasgow
- Patrick Mallia, Senior Clinical Lecturer, Imperial College London
- Philip E Silkoff, Senior Director, Immunology, Pulmonary Disease Area, Janssen Inc
- Robert Niven, Senior Lecturer in Respiratory Medicine, Manchester University
- Roland Kolbeck, Respiratory, Inflammation & Autoimmunity, MedImmune
- Samantha Walker, Executive Director, Research & Policy, Asthma UK
- Sebastian Johnston, Professor of Respiratory Medicine, National Heart and Lung Institute, Imperial College London
- Sejal Saglani, Reader in Respiratory Paediatrics, Imperial College London
- Staffan Edsbacker, Global Project Director and Associate Professor, AstraZeneca R&D Mölndal and University of Lund
Please fill in your name and email to receive the conference agenda of this event.
The agenda is available as PDF under downloads at the right side of the page.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
Who Should Attend
Chief Executives, Chief Scientific Officers, Chief Medical Officers, Vice Presidents, Heads, Directors, Senior Scientist, Principle Scientists, Clinicians, Physicians, Project Leaders, Specialists, and Managers in the following areas:
- Respiratory Physiology & Medicine
- Respiratory Pharmacology
- Regulatory and Medical Affairs
- Inflammatory Disease
- Respiratory, Inflammation and Autoimmunity
- Pulmonary Disease
- Respiratory Therapeutics
- Immunology
- Medical & Inhalation Devices
- In-Vitro Biology
- Biomarker
- Inflammation Discovery
- Preclinical R&D
- Clinical Pharmacology
- Clinical Trials
- Research and Development
- Business Development
- Brand Manager
- Commercial
- Respiratory
Venue
Holiday Inn Regents ParkCarburton Street
London
W1W 5EE England
